Journal of Experimental Therapeutics and Oncology

Editor-in-Chief: Dominic Fan
ISSN: 1359-4117 (print)
ISSN: 1533-869X (online)
80 pages/issue ยท 8.5" x 11"
Issue Coverage: Volume 4 (2004) - Present

Aims and Scope

The journal is devoted to the rapid publication of innovative preclinical investigations on therapeutic agents against cancer and pertinent findings of experimental and clinical oncology.

In the journal you will find review articles, original articles, and short communications on all areas of cancer research, including but not limited to preclinical experimental therapeutics; anticancer drug development; cancer biochemistry; biotechnology; carcinogenesis; cancer cytogenetics; clinical oncology; cytokine biology; epidemiology; molecular biology; pathology; pharmacology; tumor cell biology; and experimental oncology.

Papers concerning work on humans must comply with the principles of the declaration of Helsinki (1964). The approval of an ethical committee must then be stated on the manuscript. The editors reserve the right to reject a paper with questionable ethical justification.

The editors of the Journal of Experimental Therapeutics and Oncology invite your contributions.

Abstracted and Indexed in:

Excerpta Medica, EMBASE, Index Medicus/MEDLINE.

The editors mourn the passing of Franz Halberg (July 5, 1919 -June 9, 2013) and offer their condolences to his family, friends, and colleagues.

Obituary

Remebering Franz Halberg